Calculate Your Salary Ranking
Home > Pain Therapeutics Salary

Pain Therapeutics Salary
  • 40
  • 44
  • 18

Pain Therapeutics average salary is $140,000, median salary is $140,000 with a salary range from $140,000 to $140,000.
Pain Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Pain Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 1 Pain Therapeutics Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Director - Quality Control 140,000-140,000 San Mateo, CA, 94401 2010 Pain Therapeutics Director - Quality Control Salaries (1)
Pain Therapeutics San Mateo, CA Salaries
Pain Therapeutics Jobs
See more Pain Thera Jobs »
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Pain Therapeutics Salaries (October 27, 2016)
Assistant Professor University of Oklahoma $42,860 Norman, OK, 73019 01/05/2015
General OMRON $65,998 Houston, TX, 77001 09/07/2015

Pain Therapeutics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Pain Therapeutics Information
  • Pain Therapeutics Inc
  • Industry: Other
  • City: San Mateo, CA
  • Pain Therapeutics, Inc. is a biopharmaceutical company that develops drugs. As of December 31, 2008, the Company had four drug candidates in clinical programs, including Remoxy, PTI-202, PTI-721 and a radio-labeled monoclonal antibody to treat metastatic melanoma. The Company is also working on a new treatment for patients with hemophilia. PTI-202 and PTI-721 are abuse-deterrent forms of opioid drugs. The Company and King Pharmaceuticals, Inc. (King) are engaged in a strategic alliance to develop and commercialize Remoxy, PTI-202, PTI-721 and other abuse-resistant opioid painkillers.(Source: 10-K)